CASI PHARMACEUTICALS, INC. Proceeds from Notes Payable
CASI PHARMACEUTICALS, INC. (CASIF) reported Proceeds from Notes Payable of $466.00 thousand for the 12-month period ending 2020-12-31, per its 20-F filed 2023-04-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2023-04-26
| Period end | Proceeds from Notes Payable 12 month |
|---|---|
| 2020-12-31 | $466.00K 20-F · filed 2023-04-26 |